Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-04-04
2006-04-04
Low, Christopher S. F. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
07022692
ABSTRACT:
Granule formulation of quetiapine and pharmaceutically acceptable salt thereof are described, as are their preparation and their use in treating diseases of the central nervous system such as psychotic disease conditions including schizophrenia.
REFERENCES:
patent: 5948437 (1999-09-01), Parikh et al.
patent: 6599897 (2003-07-01), Brown
patent: 2002/0142050 (2002-10-01), Straub et al.
patent: WO 97/45124 (1997-12-01), None
PCT/GB00/03598 International Search Report (Dec. 2000).
AstraZeneca AB
Cochran Karen
Low Christopher S. F.
Royds Leslie A.
LandOfFree
Quetiapine granules does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quetiapine granules, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quetiapine granules will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3596640